Cormorant Asset Management as of June 30, 2014
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 54 positions in its portfolio as reported in the June 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Receptos | 5.4 | $20M | 479k | 42.60 | |
| Omeros Corporation (OMER) | 5.2 | $20M | 1.1M | 17.40 | |
| Questcor Pharmaceuticals | 4.9 | $19M | 200k | 92.49 | |
| Karyopharm Therapeutics (KPTI) | 4.7 | $18M | 385k | 46.55 | |
| Dyax | 4.6 | $17M | 1.8M | 9.60 | |
| Celgene Corporation | 4.6 | $17M | 200k | 85.88 | |
| BioCryst Pharmaceuticals (BCRX) | 3.9 | $15M | 1.2M | 12.75 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 3.9 | $15M | 100k | 147.01 | |
| Puma Biotechnology (PBYI) | 3.6 | $14M | 208k | 66.00 | |
| Arrowhead Resh Corp Com New | 3.4 | $13M | 900k | 14.31 | |
| Akebia Therapeutics (AKBA) | 2.9 | $11M | 400k | 27.79 | |
| Galectin Therapeutics Com New (GALT) | 2.9 | $11M | 800k | 13.81 | |
| Tesaro | 2.5 | $9.3M | 300k | 31.11 | |
| Heron Therapeutics (HRTX) | 2.3 | $8.6M | 700k | 12.32 | |
| Dex (DXCM) | 2.1 | $7.9M | 200k | 39.66 | |
| Sangamo Biosciences (SGMO) | 2.0 | $7.6M | 500k | 15.27 | |
| Mallinckrodt Pub SHS | 1.9 | $7.2M | 90k | 80.02 | |
| Acelrx Pharmaceuticals | 1.9 | $7.2M | 700k | 10.25 | |
| Novavax | 1.8 | $6.9M | 1.5M | 4.62 | |
| Acceleron Pharma | 1.8 | $6.8M | 200k | 33.97 | |
| Sorrento Therapeutics Com New (SRNE) | 1.8 | $6.8M | 1.0M | 6.75 | |
| Chimerix (CMRX) | 1.7 | $6.6M | 300k | 21.94 | |
| Portola Pharmaceuticals | 1.5 | $5.8M | 200k | 29.18 | |
| Merck & Co (MRK) | 1.5 | $5.8M | 100k | 57.85 | |
| Eagle Pharmaceuticals (EGRX) | 1.5 | $5.7M | 400k | 14.33 | |
| Versartis | 1.5 | $5.6M | 200k | 28.04 | |
| Ultragenyx Pharmaceutical (RARE) | 1.4 | $5.4M | 120k | 44.89 | |
| Applied Genetic Technol Corp C | 1.3 | $5.1M | 219k | 23.10 | |
| Alkermes SHS (ALKS) | 1.3 | $5.0M | 100k | 50.33 | |
| Rockwell Medical Technologies | 1.3 | $4.8M | 400k | 11.99 | |
| Array BioPharma | 1.2 | $4.6M | 1.0M | 4.56 | |
| Puma Biotechnology Call | 1.2 | $4.5M | 5.0k | 900.00 | |
| Nanostring Technologies (NSTGQ) | 1.2 | $4.5M | 300k | 14.95 | |
| Neurocrine Biosciences (NBIX) | 1.2 | $4.5M | 300k | 14.84 | |
| China Biologic Products | 1.2 | $4.4M | 100k | 44.47 | |
| Quotient | 1.1 | $4.2M | 500k | 8.36 | |
| Recro Pharma | 1.1 | $4.0M | 500k | 8.01 | |
| Glycomimetics (GLYC) | 1.1 | $4.0M | 472k | 8.43 | |
| Ptc Therapeutics I (PTCT) | 1.0 | $3.9M | 150k | 26.14 | |
| Genvec Com New | 0.9 | $3.4M | 1.3M | 2.57 | |
| Alnylam Pharmaceuticals (ALNY) | 0.8 | $3.2M | 50k | 63.18 | |
| Alder Biopharmaceuticals | 0.8 | $3.0M | 150k | 20.07 | |
| Clovis Oncology | 0.8 | $2.9M | 70k | 41.41 | |
| Agenus Com New | 0.8 | $2.9M | 900k | 3.22 | |
| Aquinox Pharmaceuticals | 0.7 | $2.8M | 300k | 9.43 | |
| Cerulean Pharma | 0.7 | $2.6M | 450k | 5.80 | |
| Auspex Pharmaceuticals | 0.6 | $2.2M | 100k | 22.27 | |
| Kindred Biosciences | 0.5 | $1.9M | 100k | 18.64 | |
| Regulus Therapeutics | 0.4 | $1.6M | 200k | 8.04 | |
| Agile Therapeutics | 0.3 | $1.3M | 150k | 8.72 | |
| ACADIA Pharmaceuticals (ACAD) | 0.3 | $1.1M | 50k | 22.60 | |
| Curis | 0.3 | $1.1M | 600k | 1.86 | |
| Scynexis | 0.2 | $802k | 100k | 8.02 | |
| Celsus Therapeutics Sponsored Adr Ne | 0.2 | $639k | 103k | 6.20 |
